PonatinibDevelopment of resistance: 3 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1787卷 / 1期

关键词：

D O I：

10.1007/s40278-020-74056-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：418 / 418

相关论文

共 50 条

[31] TemozolomideDrug resistance and various toxicities: 3 case reports [J].

Reactions Weekly, 2016, 1598 (1) :198-198

[32] Azacitidine/ivosidenibEmergence of acquired resistance: 3 case reports [J].

Reactions Weekly, 2021, 1847 (1) :88-88

[33] Fosfomycin tromethamineDiarrhoea and drug resistance: 3 case reports [J].

Reactions Weekly, 2019, 1776 (1) :202-202

[34] Avibactam/ceftazidimeAcquired drug resistance : 3 case reports [J].

Reactions Weekly, 2022, 1936 (1) :110-110

[35] AzithromycinDevelopment of resistance for Mycoplasma genitalium: 3 case reports [J].

Reactions Weekly, 2016, 1586 (1) :55-55

[36] Erlotinib/gefitinib/osimertinibAcquired drug resistance: 3 case reports [J].

Reactions Weekly, 2019, 1752 (1) :158-158

[37] Daclatasvir/sofosbuvirTreatment relapse and drug resistance: 3 case reports [J].

Reactions Weekly, 2023, 1946 (1) :192-192

[38] Entrectinib/larotrectinib/selitrectinibAcquired drug resistance: 3 case reports [J].

Reactions Weekly, 2019, 1780 (1) :149-149

[39] Ganciclovir/valganciclovirLeucopenia and development of resistance to ganviclovir: 3 case reports [J].

Reactions Weekly, 2017, 1639 (1) :134-134

[40] Multiple drugsAcquired resistance and lack of efficacy: 3 case reports [J].

Reactions Weekly, 2025, 2043 (1) :230-230

← 1 2 3 4 5 →